STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer

被引:80
作者
Awasthi, Nagendra [1 ,2 ]
Liongue, Clifford [1 ,2 ]
Ward, Alister C. [1 ,2 ]
机构
[1] Deakin Univ, Sch Med, Pigdons Rd, Geelong, Vic 3216, Australia
[2] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat IMPACT, Geelong, Vic, Australia
关键词
STAT; JAK; Cytokine; Transcription factor; Immunity; Cancer; SIGNAL TRANSDUCER; DNA-BINDING; TYROSINE PHOSPHORYLATION; UNPHOSPHORYLATED STAT3; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SERINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; JAK/STAT PATHWAY; CYCLOOXYGENASE-2; EXPRESSION;
D O I
10.1186/s13045-021-01214-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
STAT proteins represent an important family of evolutionarily conserved transcription factors that play key roles in diverse biological processes, notably including blood and immune cell development and function. Classically, STAT proteins have been viewed as inducible activators of transcription that mediate cellular responses to extracellular signals, particularly cytokines. In this 'canonical' paradigm, latent STAT proteins become tyrosine phosphorylated following receptor activation, typically via downstream JAK proteins, facilitating their dimerization and translocation into the nucleus where they bind to specific sequences in the regulatory region of target genes to activate transcription. However, growing evidence has challenged this paradigm and identified alternate 'non-canonical' functions, such as transcriptional repression and roles outside the nucleus, with both phosphorylated and unphosphorylated STATs involved. This review provides a revised framework for understanding the diverse kaleidoscope of STAT protein functional modalities. It further discusses the implications of this framework for our understanding of STAT proteins in normal blood and immune cell biology and diseases such as cancer, and also provides an evolutionary context to place the origins of these alternative functional modalities.
引用
收藏
页数:17
相关论文
共 162 条
[11]   SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ [J].
Begitt, Andreas ;
Droescher, Mathias ;
Knobeloch, Klaus-Peter ;
Vinkemeier, Uwe .
BLOOD, 2011, 118 (04) :1002-1007
[12]   PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis [J].
Berger, A. ;
Hoelbl-Kovacic, A. ;
Bourgeais, J. ;
Hoefling, L. ;
Warsch, W. ;
Grundschober, E. ;
Uras, I. Z. ;
Menzl, I. ;
Putz, E. M. ;
Hoermann, G. ;
Schuster, C. ;
Fajmann, S. ;
Leitner, E. ;
Kubicek, S. ;
Moriggl, R. ;
Gouilleux, F. ;
Sexl, V. .
LEUKEMIA, 2014, 28 (03) :629-641
[13]   Stat5a serine phosphorylation -: Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity [J].
Beuvink, I ;
Hess, D ;
Flotow, H ;
Hofsteenge, J ;
Groner, B ;
Hynes, NE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10247-10255
[14]   Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha [J].
Bhattacharya, S ;
Eckner, R ;
Grossman, S ;
Oldread, E ;
Arany, Z ;
DAndrea, A ;
Livingston, DM .
NATURE, 1996, 383 (6598) :344-347
[15]   COMBINATORIAL ASSOCIATION AND ABUNDANCE OF COMPONENTS OF INTERFERON-STIMULATED GENE FACTOR-3 DICTATE THE SELECTIVITY OF INTERFERON RESPONSES [J].
BLUYSSEN, HAR ;
MUZAFFAR, R ;
VLIESTSTRA, RJ ;
VANDERMADE, ACJ ;
LEUNG, S ;
STARK, GR ;
KERR, IM ;
TRAPMAN, J ;
LEVY, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5645-5649
[16]   Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers [J].
Brachet-Botineau, Marie ;
Polomski, Marion ;
Neubauer, Heidi A. ;
Juen, Ludovic ;
Hedou, Damien ;
Viaud-Massuard, Marie-Claude ;
Prie, Gildas ;
Gouilleux, Fabrice .
CANCERS, 2020, 12 (01)
[17]   Serine-727 Phosphorylation Activates Hypothalamic STAT-3 Independently From Tyrosine-705 Phosphorylation [J].
Breit, Andreas ;
Besik, Valeria ;
Solinski, Hans Juergen ;
Muehlich, Susanne ;
Glas, Evi ;
Yarwood, Stephen J. ;
Gudermann, Thomas .
MOLECULAR ENDOCRINOLOGY, 2015, 29 (03) :445-459
[18]   Novel level of signalling control in the JAK/STAT pathway revealed by in situ visualisation of protein-protein interaction during Drosophila development [J].
Brown, S ;
Hu, N ;
Hombría, JCG .
DEVELOPMENT, 2003, 130 (14) :3077-3084
[19]   STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription [J].
Caldenhoven, E ;
vanDijk, TB ;
Solari, R ;
Armstrong, J ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
deGroot, RP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13221-13227
[20]   STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation [J].
Canaria, D. Alejandro ;
Yan, Bingyu ;
Clare, Maia G. ;
Zhang, Zonghao ;
Taylor, Grace A. ;
Boone, David L. ;
Kazemian, Majid ;
Olson, Matthew R. .
JOURNAL OF IMMUNOLOGY, 2021, 207 (05) :1265-1274